STOCK TITAN

Transcat director awarded 1,671 RSUs, 1,587 vest

Transcat director Kaniki Mbago M. reported RSU grants, RSU vesting into common stock, and a fully vested stock option position.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TRANSCAT INC (TRNS) director Kaniki Mbago M. reported equity award and vesting activity. On September 9, 2026, the director received 1,671 restricted stock units (RSUs), which vest on September 9, 2027. On September 10, 2026, 1,587 RSUs vested and converted 1-for-1 into common shares, increasing direct common stock holdings to 4,180 shares. The director also holds a fully vested stock option covering 10,000 shares at an exercise price of $47.14 per share, expiring May 12, 2031. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Kaniki Mbago M.
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F3 1,587 $0.00 $0.00
Exercise Common Stock, $.50 par value F1 1,587 $0.00 $0.00
Grant/Award Restricted Stock Units F1, F2 1,671 $0.00 $0.00
holding Stock Option (Right to Buy) F4 -- -- --
Holdings After Transaction: Restricted Stock Units — 1,671 contracts (Direct); Common Stock, $.50 par value — 4,180 shares (Direct); Stock Option (Right to Buy) — 10,000 contracts (Direct)
Footnotes (4)
  1. F1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. F2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 9, 2027.
  3. F3. These RSUs vested on September 10, 2026.
  4. F4. This option is fully vested and exercisable as of the date of this report.
RSUs granted 1,671 units Restricted stock units granted on September 9, 2026
RSUs vested and converted 1,587 units/shares RSUs vested and converted into common stock on September 10, 2026
Common shares held after transaction 4,180 shares Direct ownership after RSU conversion on September 10, 2026
Stock option underlying shares 10,000 shares Shares underlying fully vested stock option held directly
Stock option exercise price $47.14 per share Exercise price of stock option expiring May 12, 2031
Stock option expiration date May 12, 2031 Expiration date of fully vested stock option
RSU vesting date (new grant) September 9, 2027 Scheduled vesting date for 1,671 RSUs granted September 9, 2026
Restricted Stock Units financial
"These restricted stock units ("RSUs") convert into common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 16b-3 regulatory
"These RSUs were granted in a transaction exempt under Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
fully vested and exercisable financial
"This option is fully vested and exercisable as of the date of this report"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) underlying 10,000 shares of common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did the TRNS director receive in this Form 4?

The director received 1,671 restricted stock units on September 9, 2026. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 9, 2027.

What RSUs vested and converted to Transcat (TRNS) common stock?

On September 10, 2026, 1,587 RSUs vested and converted into 1,587 shares of common stock on a one-for-one basis. Following this conversion, the director held 4,180 shares of Transcat common stock directly.

How many Transcat (TRNS) common shares does the director hold after these transactions?

After the RSU vesting and conversion on September 10, 2026, the director held 4,180 shares of Transcat common stock directly. This reflects the addition of 1,587 newly issued shares from vested RSUs.

What stock options does the TRNS director hold according to this filing?

The director holds a stock option to acquire 10,000 shares of Transcat common stock at an exercise price of $47.14 per share. This option is fully vested and exercisable and expires on May 12, 2031.

Were the TRNS transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox is not selected, so no Rule 10b5-1 trading plan is reported in connection with these equity award and vesting transactions.

How do the RSUs granted to the TRNS director convert into common stock?

The filing states that these restricted stock units convert into common stock on a one-for-one basis. That means each RSU, once vested, converts into one share of Transcat common stock, subject to the terms of the award agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kaniki Mbago M.

(Last)(First)(Middle)
C/O TRANSCAT, INC.
35 VANTAGE POINT DRIVE

(Street)
ROCHESTER NEW YORK 14624

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TRANSCAT INC [ TRNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $.50 par value09/10/2026M1,587A$0(1)4,180D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0(1)09/09/2026A1,671 (2) (2)Common Stock, $.50 par value1,671$01,671D
Restricted Stock Units$0(1)09/10/2026M1,587 (3) (3)Common Stock, $.50 par value1,587$00D
Stock Option (Right to Buy)$47.14 (4)05/12/2031Common Stock, $.50 par value10,00010,000D
Explanation of Responses:
1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 9, 2027.
3. These RSUs vested on September 10, 2026.
4. This option is fully vested and exercisable as of the date of this report.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kristina L. Johnston, Attorney-in-Fact for Mbago M. Kaniki09/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading